Glaucoma Clinical Trial
Official title:
VisionBlue for the Assessment of Filtering Bleb Functioning During Cataract Surgery
The investigators aim to conduct a prospective clinical pilot study to investigate the use of VisionBlue staining administered during cataract surgery to 20 patients with history of trabeculectomy for glaucoma as a means to assess functioning of an existing filtering bleb. The investigators also aim to develop a standard classification system for assessing filtering bleb function during cataract surgery.
Twenty (20) patients with history of trabeculectomy who have been scheduled for cataract
extraction with posterior chamber intraocular lens implant, will be recruited from Wills Eye
Hospital Glaucoma Service.
Subjects will undergo a comprehensive ophthalmic evaluation prior to scheduling cataract
surgery. The following data will be recorded: Demographic information including age, race,
and gender, Best corrected visual acuity, IOP measured by Goldmann applanation tonometry,
Bleb morphology evaluation using the Indiana Bleb Appearance Grading Scale (IBAGS),
Filtering bleb photographs and anterior segment OCT of the bleb will be taken at the
baseline examination.
The patient will be taken to the operating room and will be prepped.Non-preserved Lidocaine
(1%) will be injected into the anterior chamber for anesthesia, followed by injection of one
complete vial of VisionBlue (0.5 mL). An injection of BSS will be administered through the
paracentesis port until the IOP is approximately 20mHg (estimated by the surgeon by
palpation), with a waiting period of 20 seconds. Another injection of BSS will then be
administered to wash out the VisionBlue. A set of microscopic photographs will be taken
through the intraoperative microscope following washout of VisionBlue, with bleb grading
performed by the physician: 1+ to 4+ stain (based on standard set of photos).
Cataract extraction will then take place following typical phacoemulsification procedure. At
the end of the case, after insertion of the intraocular lens implant into the capsular bag
and removal of viscoelastic material from the eye, an additional set of microscope
photographs will be taken and graded on same scale.
The time (in minutes) between the initial and the final bleb grading will be measured and
recorded. Intraoperative complications will be recorded as well.
Follow-up of subjects will take place post-operatively at 1 day, 1 week, 1 month, 3 month,
and 6 month follow-up visits. Color photos of bleb will be performed post-operatively at 1
day, 1 month, and 6 months. At each visit, we will also record the number of glaucoma
medications, post-operative complications and need for re-operations.
;
Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
| Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
| Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
| Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
| Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
| Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
| Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
| Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
| Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
| Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
| Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
| Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
| Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
| Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
| Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
| Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
| Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A | |
| Completed |
NCT02246764 -
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 | |
| Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
| Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A |